Metabolomics Market Poised to Hit $7.92 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Metabolomics Market Size Growth Forecast: What to Expect by 2025?
The realm of metabolomics has experienced a swift expansion recently, projecting a valuation increase from $3.62 billion in 2024 to $4.17 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.1%; this historic upward trajectory has been fueled by progress across several sectors including healare improvements, innovations in pharmaceutical research and development, breakthroughs in pinpointing disease biomarkers, developments within academic and research establishments, and forward momentum in nutrition and food science disciplines.

How Will the Metabolomics Market Size Evolve and Grow by 2029?
Anticipated over the coming years is a swift expansion in the scope of the metabolomics market, projected to reach a valuation of $7.92 billion by 2029, fueled by a compound annual growth rate (CAGR) of 17.4%. This forward growth trajectory is underpinned by advancements and increasing focus across several domains: personalized healare approaches, ensuring the safety and effectiveness of pharmaceuticals, deeper understanding of the microbiome and gut health, practical applications in environmental and agricultural sectors, and progress in regenerative medicine. Key developments set to shape this market moving forward encompass the fusion of metabolomics with other omics technologies, the refinement of targeted metabolomics techniques, the development of single-cell metabolomics, the increasing reliance on data analytics and artificial intelligence, and the proliferation of point-of-care testing solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

What Drivers Are Propelling the Growth of Metabolomics Market Forward?
The expanding incidence of cancer is fueling the expansion of the metabolomics market, given that metabolomics facilitates the detection of potential biomarkers such as distinct cells, molecules, genes, gene products, enzymes, or hormones, which are utilized to assess how effectively cancer drugs work and to assist in earlier detection. As an illustration, projections from the American Cancer Society, a professional body in the US, estimated that in 2023 the United States would see 1,958,310 new cancer diagnoses and 609,820 fatalities due to cancer, marking an uptick from prior years. Various metabolomic methodologies, including nuclear magnetic resonance (NMR) and mass spectrometry (MS), are being employed in cancer research, and entities such as Metabolon Inc. and Bruker Corp. have incorporated these metabolomics tools for the early identification and treatment development for the disease.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

Which Emerging Trends Are Transforming the Metabolomics Market in 2025?
The rising adoption of machine learning within metabolomics is being fueled by its capacity to enhance the efficiency with which data derived from metabolomics methodologies can be interpreted. Technologies leveraging machine learning facilitate the automatic handling of procedures that are both complex and prone to error, simultaneously eliminating tasks that are tedious and drawn-out, thereby delivering swift and precise outcomes. Within the sector, various enterprises are gravitating towards employing machine learning approaches for examining metabolism, aiming to resolve intricate issues, streamline operations, and carry out necessary assignments. Certain machine learning models are instrumental in scrutinizing metabolic data and constructing models of metabolic pathways. Leading organizations like Bio-Rad Laboratories and Metabolon Inc. have notably begun integrating these algorithms to foster superior comprehension and predictive capabilities in metabolomics investigations. For example, MeltDB 2.0, which functions as a machine learning application, supports research by analyzing and consolidating metabolomics experiment data, while also managing experimental datasets. These sophisticated machine learning platforms frequently furnish extensive analytical tools and visual representations essential for accurately depicting voluminous and intricate datasets.

What Are the Key Segments in the Metabolomics Market?
The metabolomicsmarket covered in this report is segmented -

1) By Product And Service: Metabolomics Instruments; Metabolomics Bioinformatics Tools And Services
2) By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors of Metabolism; Other Indications
3) By Application: Biomarker Discovery; Drug Discovery; Toxicology Testing; Nutrigenomics; Functional Genomics; Personalized Medicine; Other Applications

Subsegments:
1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography); Mass Spectrometry Instruments (LC-MS, GC-MS); NMR Instruments (Nuclear Magnetic Resonance); Others (Spectroscopy Instruments, Microarrays)
2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools); Database Services (Metabolomic Databases); Consulting Services (Data Interpretation, Analytical Support); Training And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2497&type=smp

Who Are the Key Players Shaping the Metabolomics Market's Competitive Landscape?
Major companies operating in the metabolomics market include Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, Kore Technologies Ltd., Dani Instruments SpA, Perkinelmer Inc., Evans Analytical Group LLC, LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Biomark Diagnostics Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Southern Research Company Inc., Alcami Corporation, Charles River Laboratories International Inc., Eremid Genomic Services LLC, Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.

What Geographic Markets Are Powering Growth in the Metabolomics Market?
North America was the largest region in the metabolomics market in 2024. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2497

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.